---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-009184"
form_type: "8-K"
ticker: "SABS"
cik: "0001833214"
company_name: "SAB Biotherapeutics, Inc."
filed_at: "2023-04-04T23:59:59+00:00"
generated_at: "2026-06-17T06:37:02.751597+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# SAB Biotherapeutics appoints Erick Lucera, former AVEO CFO, to Board of Directors

## Summary
- Erick Lucera appointed to SAB Biotherapeutics Board effective April 4, 2023; term until next annual meeting.
- Lucera most recently served as CFO of AVEO Oncology through its acquisition by LG Chem; prior CFO at Valeritas and Viventia Bio.
- With 30+ years in biotech/med device finance, he brings experience in corporate finance, M&A, and public offerings.
- Compensation consistent with other non-employee directors as described in the 2022 proxy statement.

## SEC filing metadata
- accession: 0001437749-23-009184
- form_type: 8-K
- ticker: SABS
- cik: 0001833214
- company_name: SAB Biotherapeutics, Inc.
- filed_at: 2023-04-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1833214/000143774923009184/0001437749-23-009184-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1833214/000143774923009184/sabs20230403_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-009184
- JSON: https://secwatch.observer/filing/0001437749-23-009184.json
- Plain text: https://secwatch.observer/filing/0001437749-23-009184.txt

## Key facts
- Executive change
  Erick Lucera was appointed as Director at SAB Biotherapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: the Board subsequently appointed, Mr. Erick Lucera to serve as a director of the Company, effective as of April 3, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1833214/000143774923009184/0001437749-23-009184-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.